Monitor for any upcoming material news (earnings, guidance, regulatory decision) that could explain the broad C-suite selling. The cluster's unanimity and seniority is a cautionary signal despite the small dollar amount relative to market cap. A follow-up Form 4 filing showing a resumption of insider buying would negate the bearish read.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 6 $265.38entry
- T+1 · 3mo ago +21.37%α +20.76% · $322.10
- T+5 · 3mo ago +17.11%α +15.89% · $310.78
- T+20 · 3mo ago +23.47%α +22.87% · $327.67
- T+60 · 18d ago +56.12%α +57.79% · $414.30
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Seven Natera insiders, including the CEO, CFO, Executive Chairman, and President of Clinical Diagnostics, sold a total of $1.70M in open-market sales over a 7-day window. This is a broad-based cluster involving the entire C-suite and a director, with no insider buying to offset. While the total value is only ~0.004% of Natera's $39.4B market cap (trivial by proportionality), the unanimity and seniority of the selling group is notable and warrants attention for potential upcoming news or a peak in the stock's recent rally.
Key Financial Metrics
Key Facts
- 7 insiders sold a total of $1.70M in open-market sales over 7 days
- CEO Steven Chapman sold ~$317K worth of shares on Aug 3
- CFO Michael Brophy sold ~$131K on Aug 4
- Executive Chairman Matthew Rabinowitz sold ~$448K on Jul 27
- President of Clinical Diagnostics Solomon Moshkevich sold ~$306K on Jul 28
- No insider open-market purchases were reported in the cluster
- Total sales represent ~0.004% of Natera's $39.4B market cap
Financial Impact
Total insider sales of $1.70M, a trivial 0.004% of market cap
Risk Factors
- Insider sales may be part of pre-arranged 10b5-1 plans or tax-related diversification, reducing the signal's information content
- The small dollar amount relative to market cap means the cluster is unlikely to move the stock on its own
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NTRA-1785981671144 |
Track record
63 reports on NTRA
6 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $319.09 +6.21% settles Nov 17
- Nov 10, 20265d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $319.09 −0.23% ▲ +0.98% +1.33% vs SPY
- Nov 10, 20266d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $319.09 −0.23% ▲ +0.98% +1.33% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $319.09 +2.71% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $319.09 +2.71% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $319.09 −12.28% ▼ −14.59% −14.91% vs SPY
- Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $319.09 −12.28% ▼ −14.59% −14.91% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $319.09 −18.40% ▼ −6.97% −2.56% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $319.09 −17.89% ▲ +0.62% −1.03% vs SPY
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $319.09 −17.89% ▲ +0.62% −1.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers